Back to BARCLAYS PLC BARCLAYS PLC

AZNAZN
2 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in ASTRAZENECA PLC

Yes. Barclays holds 6,592,403 shares of AZN (AstraZeneca), worth $1.3B, as of its Q2 2026 13F filing. It increased the position by 1,100,411 shares (+20.0%) from Q1 2026. Barclays has held AZN in every 13F on record since Q1 2026, 2 quarterly filings. AZN is 0.2% of Barclays' reported 13F portfolio.

Current Value

$1.3B

Current Shares

6.6M

Total Value Change

+$166.9M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.6M
+20.0%
$1.3B0.2%$189.62
45
2026-Q1
New
5.5M
-
$1.1B0.3%$197.22
53

Other major holders of AZN: VANGUARD CAPITAL MANAGEMENT LLC, Capital International Investors, NORGES BANK

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used